Tag: Pharma
Mayne Pharma and Mithra Announce FDA Approval of HLOETTE®, a Generic Version of NUVARING® – 08/08/2022 at 07:30
August 08, 2022, 07:30 CEST – Adelaide, Australia and Liège, Belgium – Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) are pleased to announce that…
Outstanding volumes today: Innate Pharma, Metabolic Explorer
During this trading session on Monday August 1, 2022, abnormal trading volumes were detected on the French market. Today, it is the Innate Pharma share that stands out, with trading…
Mithra announces the launch by Mayne Pharma of the new NEXTSTELLIS® consumer campaign in the United States – 08/01/2022 at 07:30
Liège, Belgium, August 01, 2022 – 7:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that its US business partner, Mayne Pharma Group Limited…
Innate pharma: Stands out, a broker initiates the purchase
Read also (CercleFinance.com) – Innate Pharma shares rose sharply on the Paris Stock Exchange on Friday, driven by the initiation of hedging on the purchase by Stifel analysts. Around 3:30…
MaaT Pharma: sufficient cash until Q3 2023
By Alexandra Saintpierre Published on 07/28/2022 at 6:46 p.m. Photo credit © Maat Pharma …
TME Pharma announces the completion of its reverse stock split – 2022-07-27 at 19:00
To receive all of the company’s financial communications in real time, please register directly by email at the following address: [email protected] Berlin, Germany, July 27, 2022, 7:00 p.m. CEST –…
Innate pharma: Selection of a second antibody by Sanofi
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
MEDESIS PHARMA receives a grant from AFM-TELETHON to finance the first phases of the development of NanosiRNA-HD, its RNA interference treatment for Huntington’s disease – 07/20/2022 at 08:00
Montpellier, July 20, 2022 at 8:00 a.m. – MEDESIS PHARMA, a pharmaceutical biotechnology company developing drug candidates based on its proprietary Aonys® technology for the administration of active ingredients in…
Noxxon Pharma becomes TME Pharma
AB Published on 07/15/2022 at 08:15 Photo credit © Noxxon Pharma …
TME Pharma announces financing of 3.24 million euros as part of the agreement with Atlas – 07/15/2022 at 18:00
To receive all of the company’s financial communications in real time, please register directly by email at the following address: [email protected] Berlin, Germany, July 15, 2022, 6:00 p.m. CEST –…
TME Pharma: financing of 3.24 million euros – 07/15/2022 at 19:13
(AOF) – TME Pharma, a biotechnology company specializing in the development of new therapies for the treatment of cancer by targeting the tumor microenvironment (MET), has entered into a transaction…
Noxxon Pharma becomes TME Pharma – 07/15/2022 at 08:42
(AOF) – TME Pharma NV, a biotechnology company specializing in the development of novel therapies for the treatment of cancer by targeting the tumor microenvironment (MET), today announces that it…